Centiva Capital LP bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 8,694 shares of the financial services provider's stock, valued at approximately $1,940,000.
Other institutional investors also recently modified their holdings of the company. Carmichael Hill & Associates Inc. increased its stake in shares of Marsh & McLennan Companies by 85.7% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 130 shares of the financial services provider's stock worth $29,000 after purchasing an additional 60 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in shares of Marsh & McLennan Companies during the 3rd quarter worth about $31,000. Crewe Advisors LLC increased its holdings in shares of Marsh & McLennan Companies by 100.0% during the 2nd quarter. Crewe Advisors LLC now owns 160 shares of the financial services provider's stock valued at $34,000 after acquiring an additional 80 shares during the last quarter. Iron Horse Wealth Management LLC boosted its position in Marsh & McLennan Companies by 712.5% during the second quarter. Iron Horse Wealth Management LLC now owns 195 shares of the financial services provider's stock worth $41,000 after purchasing an additional 171 shares during the period. Finally, Ridgewood Investments LLC bought a new position in shares of Marsh & McLennan Companies in the second quarter valued at approximately $41,000. Institutional investors and hedge funds own 87.99% of the company's stock.
Marsh & McLennan Companies Price Performance
Shares of MMC traded down $2.03 on Tuesday, hitting $231.01. The company's stock had a trading volume of 1,324,645 shares, compared to its average volume of 1,692,932. The company has a 50 day moving average price of $224.26 and a 200 day moving average price of $219.89. Marsh & McLennan Companies, Inc. has a fifty-two week low of $184.28 and a fifty-two week high of $235.50. The company has a market capitalization of $113.45 billion, a PE ratio of 28.70, a PEG ratio of 2.81 and a beta of 0.94. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.14 and a quick ratio of 1.14.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last announced its earnings results on Thursday, October 17th. The financial services provider reported $1.63 EPS for the quarter, topping the consensus estimate of $1.61 by $0.02. Marsh & McLennan Companies had a return on equity of 32.65% and a net margin of 16.82%. The company had revenue of $5.70 billion for the quarter, compared to analysts' expectations of $5.71 billion. During the same quarter in the prior year, the business earned $1.57 earnings per share. The business's revenue for the quarter was up 5.9% on a year-over-year basis. On average, research analysts anticipate that Marsh & McLennan Companies, Inc. will post 8.68 earnings per share for the current fiscal year.
Marsh & McLennan Companies Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 4th were issued a $0.815 dividend. This represents a $3.26 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date was Friday, October 4th. Marsh & McLennan Companies's dividend payout ratio is currently 40.15%.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on MMC shares. Roth Mkm raised their target price on Marsh & McLennan Companies from $220.00 to $230.00 and gave the company a "neutral" rating in a report on Friday, October 18th. Barclays increased their price target on shares of Marsh & McLennan Companies from $236.00 to $246.00 and gave the company an "equal weight" rating in a report on Thursday, November 21st. BMO Capital Markets increased their target price on shares of Marsh & McLennan Companies from $217.00 to $228.00 and gave the company a "market perform" rating in a research note on Tuesday, October 22nd. Keefe, Bruyette & Woods boosted their price target on Marsh & McLennan Companies from $209.00 to $212.00 and gave the company an "underperform" rating in a research note on Tuesday, October 22nd. Finally, Bank of America raised their price objective on Marsh & McLennan Companies from $248.00 to $250.00 and gave the stock a "neutral" rating in a research report on Thursday, October 10th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $227.60.
Get Our Latest Report on MMC
Insider Buying and Selling
In other Marsh & McLennan Companies news, Director Oscar Fanjul sold 2,500 shares of the firm's stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $221.55, for a total value of $553,875.00. Following the transaction, the director now directly owns 48,549 shares of the company's stock, valued at approximately $10,756,030.95. This trade represents a 4.90 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.35% of the stock is currently owned by corporate insiders.
About Marsh & McLennan Companies
(
Free Report)
Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.
Further Reading
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.